跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
NORSPAN buprenorphine 40 micrograms/h transdermal drug delivery system sachet
Approved
STANDARD
NORSPAN buprenorphine 40 micrograms/h transdermal drug delivery system sachet
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
539045cf2e3afc31
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
539045cf2e3afc31
Product Name
NORSPAN buprenorphine 40 micrograms/h transdermal drug delivery system sachet
Artg Id
217510
Artg Name
NORSPAN buprenorphine 40 micrograms/hour transdermal drug delivery system sachet
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
2014-11-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-07759-4
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-06126-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
539045cf2e3afc31
Type
Standard
Back to TGA Approvals
NORSPAN buprenorphine 40 micrograms/h transdermal drug delivery system sachet - TGA Drug Approval Details